verified SJR 0,667 · Q2 • database Scopus / SJR & Web of Science indexed

United Arab Emirates · Bentham Science Publishers

workspace_premium Q2 — Medicine (miscellaneous) lock Subscription

Recent Patents on Anti-Cancer Drug Discovery

Recent Patents on Anti-Cancer Drug Discovery is a journal indexed in SJR in Medicine (miscellaneous) and Drug Discovery with an H index of 54. It has an SJR impact factor of 0,667 and it has a best quartile of Q2. It has an SJR impact factor of 0,667.

ISSN: 1574-8928

Publisher: Bentham Science Publishers

Category: Medicine (miscellaneous)

Indexation: verifiedScopus / SJR verifiedWeb of Science

open_in_new Portal NPD menu_book Guidelines NPD

schedule CountryOfPapers database fields

SJR Impact Factor trending_up

0,667 Q2

H-index 54

Acceptance rate pie_chart

31%

Source Acceptance_Rate

Time to publication hourglass_top

NPD

Field NPD

Publication cost (APC) payments

NPD Subscription

Non-OA path NPD

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

SJR Impact

0,667

H-index

Docs (year)

Docs 3y

118

Total refs

3364

Cites 3y

410

Citable 3y

113

Cites/Doc 2y

3.92

Ref/Doc

67.28

Immediate OA

—

Embargoed OA

NPD

Non OA / Submission

—

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Characterization of Solid Lipid Nanoparticles Containing Caffeic Acid and Determination of its Effects on MCF-7 Cells

Voltage-Gated Ion Channels, New Targets in Anti-Cancer Research

HER3 and its Ligand, Heregulin, as Targets for Cancer Therapy

Glycolysis Inhibitors for Anticancer Therapy: A Review of Recent Patents

Experimental Research on a Novel Iodine-125 Seed Strand Connected Using Magnesium Alloy AZ31

Episomal Lentiviral Vector-Mediated miR-145 Overexpression Inhibits Proliferation and Induces Apoptosis of Human Esophageal Carcinomas Cells

Epigenetics in Medullary Thyroid Cancer: From Pathogenesis to Targeted Therapy

Editorial [Hot topic: Developing New Anti-Cancer Drugs (Guest Editor: Ricardo De Souza Pereira)]

Editorial [Hot topic: Breast Cancer: Novel Therapeutic Targets (Guest Editor: George W. Yip)]

Development of Taxol and Other Endophyte Produced Anti-Cancer Agents

Developing Antitumor Magnetic Hyperthermia: Principles, Materials and Devices

Contemporary Formulations for Drug Delivery of Anticancer Bioactive Compounds

SHOW MORE ARTICLES

Compositions for Treatment of Cancer and Inflammation

"Impact of Smoking Cessation Treatment" on Lung Function and Response Rate in EGFR Mutated Patients: A Short-Term Cohort Study

Cell-Based Assay System to Estimate the Effect of 125I Seeds on Cancer Cells: Effect of Osteopontin

Cell Cycle and Energy Metabolism in Tumor Cells: Strategies for Drug Therapy

Causal Therapy of Breast Cancer Irrelevant of Age, Tumor Stage and ER-Status: Stimulation of Estrogen Signaling Coupled With Breast Conserving Surgery*

Calcium Channels and Prostate Cancer

Cabozantinib in Thyroid Cancer

Bortezomib -First Therapeutic Proteasome Inhibitor for Cancer Therapy: A Review of Patent Literature

Author Index To Volume 1

Anticancer Drug Discovery from the Marine Environment

Anti-HER2 Treatment and Breast Cancer: State of the Art, Recent Patents, and New Strategies

Anti-Epidermal Growth Factor Receptor Antibodies in the Treatment of Metastatic Colorectal Cancer

FAQs

Recent Patents on Anti-Cancer Drug Discovery has an SJR of 0,667 (best quartile Q2) in the CountryOfPapers database.

Immediate OA APC is not available (NPD).

The acceptance rate recorded for Recent Patents on Anti-Cancer Drug Discovery is 31%.

Recent Patents on Anti-Cancer Drug Discovery

Metrics

Name good journals. Call out predatory ones.

Researcher reviews

Best articles by citations

FAQs

What is the SJR of Recent Patents on Anti-Cancer Drug Discovery?

What is the APC / publication cost?

What is the acceptance rate?